Immunological enhancement of primary tumor development and its prevention
- 31 October 2000
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 10 (5) , 351-357
- https://doi.org/10.1006/scbi.2000.0331
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent MiceScandinavian Journal of Immunology, 1997
- Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal miceEuropean Journal of Immunology, 1996
- Methylcholanthrene‐induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expressionAPMIS, 1996
- Interferon γ-Inducible Protein-10 (IP-10), a Member of the C-X-C Chemokine Family, Is an Inhibitor of AngiogenesisBiochemical and Biophysical Research Communications, 1995
- CD4-POSITIVE AND B LYMPHOCYTES IN TRANSPLANTATION IMMUNITYTransplantation, 1993
- CD4+ AND B LYMPHOCYTES IN TRANSPLANTATION IMMUNITYTransplantation, 1993
- Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinicJournal of Clinical Immunology, 1991
- Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.The Journal of Experimental Medicine, 1988
- Suppressor T Lymphocytes Control the Development of Primary Skin Cancers in Ultraviolet-Irradiated MiceScience, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982